Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

SHANDONG XINHUA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 43
  • 0 comments

FDA approve SEVELAMER CARBONATE

Comment Full text

SCHERING

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 41
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

MERCK SHARP DOHME

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 33
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

NEXUS PHARMS

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 49
  • 0 comments

FDA approve MINOCYCLINE HYDROCHLORIDE

Comment Full text

BARR

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 39
  • 0 comments

FDA approve ISONIAZID

Comment Full text

BARR

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 41
  • 0 comments

FDA approve ISONIAZID

Comment Full text

MERCK SHARP DOHME

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 36
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 40
  • 0 comments

FDA approve POSACONAZOLE

Comment Full text

MAYNE PHARMA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 37
  • 0 comments

FDA approve ITRACONAZOLE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Oct. 28, 2024, 08:58 UTC
  • 42
  • 0 comments

FDA approve FLUOXETINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 280
  • 281
  • 282
  • 283
  • 284
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2016)
  • SEC News(184759)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122449)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin